Skip to main content

SureshBKatakkarMDFRCPC FACP

Oncology Tucson, AZ

Arizona hematology oncology

Dr. Katakkar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Katakkar's full profile

Already have an account?

Education & Training

  • Certified by International Academy of Thrombosis/Hemostatis
    Certified by International Academy of Thrombosis/HemostatisBoard Certified, thrombosis and bleeding disorders, 1995 - 1995
  • Royal College of Physicians
    Royal College of PhysiciansFellow, 1976 - 1976
  • W. W. Cross Cancer Institute
    W. W. Cross Cancer InstituteFellowship, Oncology, 1974 - 1975
  • General Hospital
    General HospitalResidency, Clinical Hematology, 1973 - 1974
  • University Hospital
    University HospitalResidency, IM, 1971 - 1972
  • St Paul Hospital
    St Paul HospitalResidency, IM, 1970 - 1971
  • St Paul Hospital
    St Paul HospitalInternship, Rotating Internship, 1969 - 1970
  • B.J. Medical College - University of Pune
    B.J. Medical College - University of PuneClass of 1969

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1979 - 2026
  • WA State Medical License
    WA State Medical License 1979 - 2025
  • MD State Medical License
    MD State Medical License 1977 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • ABQAURPCHCQM FABQAURP (2019)
  • ABQAURPFABQAURB
  • ACPFACP
  • Europian Society of Medical Oncologymedical oncology
  • International Society Of Thrombosis and HemostasisThrombosis and Hemostasis
  • London RCPScD

Publications & Presentations

PubMed

Journal Articles

  • Prolonged Thrombin Time in Asymptomatic Patient with Hypo Dysfibrogememia Tucson  
    Suresh B Katakkar, Journal of Hematalogy and Oncology Research - 4(2):7-8, 8/24/2021
  • Chemohormonal Therapy with Combination Nitrogen Mustard and Stilphosterol in Resistant Metastatic Carcinoma of the Prostrate.  
    Katakkar, S.B., American Society of Clinical Oncology Twentieth Annual Meeting, May 6-8, 1984, Toronto, Vol. 3, p. 1
  • Phase II Evaluation of Cisplatin, 5FU and Mitomycin in Poorly Differentiated Adenocarcinoma of the Lung.  
    Katakkar, S.B., Fourth World Conference on Lung Cancer
  • Join now to see all

Abstracts/Posters

  • Spur Cell Anaemia in Cirrhosis.
    Katakkar, S.B. and McLeish, W.A., 6th Annual Meeting of the Ontario Association of Pathologists
  • Combination Chemotherapy of Stage III Testicular Cancer.
    MacDonald, R.N., Turner, A.R., McPhee, M., Katakkar, S.B., Annual Meeting of the Royal College of Physicians and Surgeons of Canada, Montreal PQ, Canada
  • Role of Chemohormonal Therapy and Alpha Interferon (Roferon) in Patients with Metastic Hypernephroma.
    Katakkar, S.B., Kuenzli, S., First International Symposium on Immunobiology of Renal Cell Carcinoma, Cleveland, Ohio
  • Join now to see all

Lectures

  • Specific Immunotherapy with Malignant Serosal Fluids. 
    Washington, DC
  • Adjuvant Chemotherapy of Non-Oat Cell Cancer of the Lung. 
    Adjuvant Therapy Conference, Arizona Cancer Center, University of Arizona

Other

  • Malignant Melanoma: Adjuvant Chemo-immunotherapy in Stage III and Chemo-immunotherapy in State IV. 
    Alexander, H.G., Paterson, T., McPherson, A., Katakkar, S.B. and Kaliq, A., Twelfth Annual Meeting of the American Society of Clinical Onocology, May 4-8, 1976, Toronto, Vol. 1
    Toronto, Canada